Maruho Co., Ltd.

This study tested whether a drug called nemolizumab could help people with systemic sclerosis, a rare disease that causes skin thickening and can affect internal organs. Six patients with moderate to severe skin symptoms received the drug for up to a year. Researchers measured ch…